Use of prophylactic antibiotics for intra-vesicle Botox® injection.
Mohammad Hassan Khan, Omer Baldo, Philip Koenig...
https://pubmed.ncbi.nlm.nih.gov/27177011/Actively Recruiting
Led by Atlantic Health System · Updated on 2024-03-27
140
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether skipping antibiotic prophylaxis before bladder Botox injections is not significantly worse than giving antibiotics. This trial focuses on female patients undergoing bladder Botox treatment. The goal is to reduce antibiotic use in this setting to help fight antibiotic resistance. The study is a randomized controlled trial comparing two groups one receiving antibiotics and one not. Participants will be randomly assigned to either the antibiotic arm or no treatment arm. Those in the antibiotic arm will receive oral antibiotics prescribed by their doctor based on allergies. Antibiotics are taken for 2 days before the Botox injection, the treatment day, and 2 days after. Everyone will have a urine culture about 14 days before the procedure to check for infection. The Botox injection technique and dose are decided by the physician. Participants return for a follow-up visit about 2 weeks after treatment to check for urinary tract infection UTI symptoms and post-void residual urine volume. They will receive a phone call again at 6 weeks for further follow-up. Researchers will monitor symptoms of UTIs, voiding problems, and any side effects related to antibiotics. Urine cultures will be done if infection symptoms occur. The main outcome is UTI occurrence 2 weeks after the procedure.
CONDITIONS
Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA
A
Anastasiya Holubyeva, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Atlantic Health System
Lead Sponsor
Columbia University
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Antibiotic prophylaxis (trial) | No prophylaxis (trial) | Guideline standard of care |
|---|---|---|---|
| What it is | Oral antibiotic given at the clinician’s discretion before Botox injection | No antibiotic is given before Botox injection | Single‑dose antibiotic before similar urologic procedures is the guideline‑recommended standard |
| Role in trial | Investigational intervention being evaluated | Comparison arm without antibiotic prophylaxis | Represents usual care standard for comparison |
| Primary use | Prevent UTI following bladder Botox injection | Assess baseline UTI risk without prophylaxis | Reduce UTI risk in urologic procedures |
| How it is given or performed | Oral antibiotic prescribed by physician prior to procedure | No antibiotics are administered before injection | Single‑dose antibiotic given before procedure, as per guidelines |
| Evidence status | Efficacy being evaluated; trial results pending | Baseline UTI risk without prophylaxis being assessed | Single‑dose prophylaxis generally accepted to reduce UTI risk in similar procedures |
| Important risks | Risks associated with antibiotic use (e.g., allergic reaction, resistance) not detailed in trial | May have higher risk of UTI without prophylaxis | Antibiotic use carries standard risks such as resistance and adverse reactions |
| Important limitations | Trial may not specify antibiotic type or duration; variable physician discretion | Does not reflect common practice where some prophylaxis is used | Guideline is not procedure‑specific and based on consensus, not direct evidence for Botox injection |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or phone) for consent and eligibility assessment
Duration - 5 days (2 days pre-treatment, treatment day, 2 days post-treatment)
Participants randomized to the antibiotic arm will receive oral antibiotics for 2 days before, on the day of, and 2 days after the Botox injection. Participants in the no antibiotic arm will undergo the Botox injection without prophylactic antibiotics.
1 treatment visit (in-person) for Botox injection
Duration - Approximately 6 weeks
Participants return for follow-up visits to assess urinary tract infection symptoms, voiding function, and any adverse events. Urine cultures will be collected when possible for participants with symptoms.
2 follow-up visits (in-person and phone) at about 2 weeks and 6 weeks post-treatment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mohammad Hassan Khan, Omer Baldo, Philip Koenig...
https://pubmed.ncbi.nlm.nih.gov/27177011/Hashim Hashim, Kathleen Beusterien, John F P Bridges...
https://pubmed.ncbi.nlm.nih.gov/26347077/Sarah E Eckhardt, Yoko Takashima, Stephanie J Handler...
https://pubmed.ncbi.nlm.nih.gov/33594517/Victor W Nitti, David Ginsberg, Karl-Dietrich Sievert...
https://pubmed.ncbi.nlm.nih.gov/27038769/Anastasiya Holubyeva, Kaythi Khin, Tess Gao...
https://pubmed.ncbi.nlm.nih.gov/39836173/Timothy A Wencewicz
https://pubmed.ncbi.nlm.nih.gov/31288031/Yuh-Chen Kuo, Hann-Chorng Kuo
https://pubmed.ncbi.nlm.nih.gov/26999201/K-D Sievert, C Chapple, S Herschorn...
https://pubmed.ncbi.nlm.nih.gov/24754838/Markus Huemer, Srikanth Mairpady Shambat, Silvio D Brugger...
https://pubmed.ncbi.nlm.nih.gov/33400359/Christopher Chapple, Karl-Dietrich Sievert, Scott MacDiarmid...
https://pubmed.ncbi.nlm.nih.gov/23608668/Atlantic Health System
Lead Sponsor
Columbia University
Collaborating Sponsor